OraSure Technologies Inc (OSUR) — Analysis Summary
OraSure Technologies Inc (OSUR) has a market cap of $273.33M with year-over-year revenue growth of -38.1%. Net margin stands at -59.8%. The stock trades at a P/E ratio of -3.6.
Key Takeaways
- Revenue changed -38.1% year-over-year
- Net margin of -59.8%
- P/E ratio of -3.6
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, OSUR posted revenue growth of -38.1% and trades at a P/E of -3.6.
OraSure Technologies Inc (OSUR)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Operating margin at -68.6% — severe operating losses
Net margin at -66.4% — significant losses
The latest filing shows negative free cash flow.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
500
Headquarters
BETHLEHEM, PA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.